Article Abstract

Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy

Authors: Shailesh Advani, Dejana Braithwaite

Abstract

Lung cancer accounts for nearly 27% of incident cancers in the United States and is the leading cause of cancer-related mortality (1). The overall five-year survival in lung cancer patients is 17% but ranges from 55% for local tumors to 4% for distant tumors (1).